中国生物制药-JPM-202401 .pdf

1、中國生物製藥有限公司SINO BIOPHARMACEUTICAL LIMITED(1177 HK)2024 J.P.Morgan Healthcare ConferenceInnovation-driven Leading Pharma Co.in ChinaJan 2024This presentation has been prepared by Sino Biopharmaceutical Co.,Ltd.(hereinafter referred to as the“Company”)for reference purposes only.By reviewing or obtaini

2、ng the information contained in this material,you hereby acknowledge and agree that the company,or any of its directors,shareholders,employees,agents,affiliates,consultants or representatives,makes no representations,warranties or undertakings,express or implied.And should not rely on the accuracy,f

3、airness,completeness or correctness of the information or opinions provided or contained in this presentation.The company or any of its directors,shareholders,employees,agents,affiliates,consultants or representatives are not(by negligence or otherwise)caused by any information provided or contained

4、 in this presentation or other reasons related to this presentation.Any liability for any loss.Information provided or contained in this presentation is subject to change without notice and is not guaranteed.This presentation does not constitute an offer to sell or issue,nor does it constitute an in

5、vitation or recommendation to purchase or subscribe for any securities sold by the Company.No part of this presentation constitutes a basis or reliance on any contract or investment decision relating to any securities or otherwise.This presentation does not contain all relevant information about the

6、 company or its securities,especially information relating to the risks and special considerations of investing in the companys securities.Nothing contained in this presentation shall be a commitment or representation of the companys past or future performance.Past performance is not guaranteed or p